We are live on ! Find out more
NRX

NEPHROGENEX INC COM
NRX

Delisted

NRX was delisted on the 10th of May, 2016.

15 hedge funds and large institutions have $9.74M invested in NEPHROGENEX INC COM in 2014 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

36% more funds holding

Funds holding: 1115 (+4)

24% less capital invested

Capital invested by funds: $12.8M → $9.74M (-$3.09M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
15
Holders Change
+4
Holders Change %
+36.36%
% of All Funds
0.44%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
6
Increased
1
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change

NRX Hedge Fund Activity: Q3 2014 in Review

15 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in NEPHROGENEX INC COM (NRX) for Q3 2014, worth a combined $9.74M — down 24% from $12.8M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new NRX positions and 2 closed out — a net gain of 4 holders — while 1 added to existing stakes and 3 trimmed.

The largest buyer was First New York Securities, opening a new position worth an estimated $116K. The largest seller was Revelation Capital Management (Bermuda), exiting entirely with an estimated $170K sold.

  • 15 institutional investors held NEPHROGENEX INC COM (NRX) as of Q3 2014, up from 11 in Q2 2014.
  • Funds reported $9.74M of NEPHROGENEX INC COM stock for Q3 2014, down 24% quarter-over-quarter.
  • 6 funds opened new NEPHROGENEX INC COM positions in Q3 2014 and 2 closed out, a net change of +4 holders.
  • The largest NEPHROGENEX INC COM buyer in Q3 2014 was First New York Securities, an estimated $116K added.
  • The largest NEPHROGENEX INC COM seller in Q3 2014 was Revelation Capital Management (Bermuda), an estimated $170K sold.

Based on aggregated 13F filings for Q3 2014.